There are some similarities and differences in the process of sexual differentiation during development in rodents and primates. The most obvious difference is in the timing of the critical periods for morphogenesis of the reproductive tract and sexual differentiation of the central nervous system (CNS). In primates these events occur late in the first trimester while in rodents they occur in the perinatal period.
INTRODUCTION
EXUAL DIFFERENTIATION IS A COMPLEX process extending from early development up to the S time of puberty in mammals. Closely timed interactions between a number of organs including the gonads, accessory organs, external genitalia, and brain are necessary for successful completion of this process (Fig. 1) . This paper provides a background for some of the key gonadal and neuroendocrine events that mediate this process. The main focus of the presentation will be to compare and contrast what is known about this process in rodents and primates, including humans.
In the human embryo the primordial germ cells first appear at 3 weeks of development among the endodermal cells in the wall of the yolk sac. They migrate by ameboid movement along the hindgut and at the 6th week settle in the genital ridges. Shortly before and during the arrival of the primordial germ cells, primitive sex cords form in the indifferent gonad. Under the influence of the Y chromosome, the primitive sex cords continue to proliferate and penetrate deep into the medulla to form the testis by 6-8 weeks of human development ( Table  I) . The Leydig cells form shortly thereafter and by 3-4 months of development produce testosterone at peak levels. Morphologic differentiation of the genital ducts, external genitalia, and central nervous system (CNS) then occur under the influence of hormone production by the testis. Two principal types of hormones are produced by the fetal testis: testosterone by the Leydig cells, which promotes male reproductive tract and CNS development, and a nonsteroidal factor by the Sertoli cells, which causes regression of the mullerian ducts.(') 
NEONATAL SEX DIFFERENTIATION RODENT VS PRIMATE
Testosterone is the androgen that promotes differentiation of the wolffian ducts to form the seminal vesicles, vas deferens. and epididymis as well as maturation of the spermatogenic tubules (Fig. 2) . In other tissues, testosterone must be transformed to dihydrotestosterone (DHT) through the enzyme steroid Sa-reductase to exert an influence on morphogenesis. DHT and not testosterone itself acts on the urogenital sinus to induce the formation' of the male urethra and prostate. DHT also shapes the anlage of the external genitalia for formation of the glans, shaft, and scrotum.@) The timing of events in morphogenesis of the male reproductive tract are different in rodent and primate species, as can be seen from data presented in Table 1 . Morphogenesis of the male reproductive system is essentially complete within the first trimester (up to week 10 of gestation) in humans while in typical laboratory animal species this process continues up through the third trimester. Other than differences in timing, however, the relative roles of testosterone and DHT on morphogenesis of the male reproductive tract are known to be identical for rodent and primate species. In the rat, rabbit, guinea pig, and human fetus, 5areductase activity is high in the anlage of the prostate and external genitalia before virilization. In contrast, in these species Sa-reductase activity is virtually undetectable in the wolffian duct derivatives (seminal vesicles, vas deferens, ejaculatory duct, epididymis) until after virilization of these tissues is ad~anced.(3-~'
Substantiation that DHT formation is important for prostate and external genitalia formation in humans has come from studies of males with a rare autosomal recessive form of pseudohermaphroditism, Sa-reductase deficiency@) ( Fig. 3) . These persons have normal to elevated plasma testosterone levels and decreased DHT levels. At birth, the patients have a male 45 XY genotype with bilateral cryptorchid testes and normally virilized wolffian duct derivatives. The external genitalia and prostate are poorly developed, and affected individuals are identified and reared as females. At puberty, however, they develop an increase in muscle mass and male habitus, deepening of the voice, growth of the phallus, rugation and hyperpigmentation of the scrotum, and testicular descent occurs in some cases. Male libido and sex drive are expressed. Animal models have been developed to mimic the morphologic aspects of this condition by treatment with Su-reductase inhibitors. When pregnant rats were given a specific 5u-reductase inhibitor from days 14 to 22 of gestation, prostate and external genitalia were underdeveloped, while the seminal vesicles, vas deferens, and epididymis were normal. Simultaneous administration of DHT with the 5a-reductase inhibitor restored normal prostate development and formation of the external genitalia.(')
These findings indicate that there are no major species differences in the roles played by the gonadal steroids testosterone and DHT in morphogenesis of the male reproductive tract. Table  2 summarizes the actions of these hormones in all species examined, including humans. Although the morphogenic actions of testosterone and DHT on the gonads and male accessory tissues are considered universal, their actions at the CNS levels during development are considerably more complex. 
SEXUAL DIFFERENTIATION OF THE CNS
The brain is a target organ for the action of gonadal steroids during development as well as during adult life. In the adult, steroids produce temporary modifications in neuronal function; this transitory action has been termed "activational." In contrast, during critical periods in development steroids have the ability to change neuronal structure and function permanently, which is referred to as "organizational." A spectrum of neuroendocrine functions, reproductive behaviors, and nonreproductive events are governed by the organizational effects of gonadal steroids, as indicated in Table 3 . Male-female differences have also been demonstrated in structural parameters such as nuclear volume, dendritic field, and synaptic organization in certain brain regions. (8) A fundamental tenet for all species is that functional and structural sex differences in the brain are not due to sex chromosome expression in neuronal tissue. These sex differences are imposed by the gonadal steroid milieu during development on an inherently female or at least bipotential brain(*) (Fig. 4) . The intrinsic pattern of CNS development is assumed to be organized along lines that are appropriate for the homogametic sex, or females in mammals. In the heterogametic sex, or males in mammals, differentiation away from this pattern occurs as a result of hormones produced by the gonads.
Male rodents normally demonstrate tonic release of gonadotropins. If the male is castrated as a neonate, a cyclic pattern of gonadotropin release typical of female rats is produced. Conversely, aromatizable androgen or estrogen administered to neonatal female rats masculinizes or defeminizes a number of neuroendocrine parameters. These "androgenized" female rats mount more frequently than normal females (masculinization), but show lordosis responses reduced to absent levels (defeminization). Male rats castrated at birth display female levels of lordosis (feminization) and cyclic gonadotropin release. These findings indicate that sex differences in neuroendocrine and behavioral responses of rodents are determined by the perinatal hormone environment.(IO)
Testosterone secreted by the fetal testes is the active agent promoting sexual differentiation of the CNS as well as of the reproductive tract. At least three molecular species of this androgen could play a role: testosterone itself, aromatized metabolites of testosterone such as estradiol, and Su-reduced metabolites such as DHT. The metabolic conversion of testosterone to DHT is irreversible, and DHT is a nonaromatizable androgen: it cannot serve as a substrate for conversion to estrogen by the aromatase enzyme.(") Several lines of evidence collectively suggest that in rodents an estrogenic metabolite of testosterone is the proximate agent in causing masculine differentiation of the brain. The enzyme aromatase is present in neonatal rat brain, and inhibitors of aromatase and estrogen receptor antagonists prevent functional sexual differentiation of the male. Estradiol benzoate is more potent than testosterone proprionate in masculinizing the brain. In rats with testicular feminizing mutation that have deficits in androgen receptors but not in estradiol receptors, sexually dimorphic nuclei in the preoptic area have volumes typical of males but not of females (reviewed in 8).
A central theory, referred to as the "aromatization hypothesis," has been proposed to explain sexual differentiation of the CNS in rodents by estrogenic substances. Testosterone is a prohormone secreted in large amounts by the fetal testes that freely diffuses into the indifferent CNS. Local intracellular metabolism by aromatase enzymes converts testosterone to estrogen, and the high estrogen nuclear receptor occupancy induces male sexual differentiation of the CNS. Endogenous estrogen levels that are elevated in male and female rodents in the perinatal period are prevented from exerting this effect by their extensive binding to a-fetoprotein (AFP). Consequently, the level of endogenous free estradiol is low, leaving relatively little hormone available for binding to cellular estrogen receptors. Exogenous estrogens, such as diethyl stibestrol (DES), are weakly bound to AFP, exist in the free state to a greater extent, are able to gain access to neuronal cells, and interact with estrogen receptors at target sites to promote virilization of the CNS.(l2)
SEXUAL DIFFERENTIATION OF THE CNS IN PRIMATES
Although the literature on the effects of gonadal steroids on differentiation of the CNS in primates is not as extensive as that for rodents, a number of pivotal studies have been conducted that can be used to compare and contrast the process in rodents vs. Old-world monkeys. As with morphogenesis of the reproductive tract, the timing of the critical period for sexual differentiation of the CNS varies in rodent and primate species ( Table 4 ). The critical period is mostly confined to the first week of neonatal life in rodents but occurs late in the first trimester of primates.
A number of studies have been conducted in which exogenous androgens (testosterone, DHT) were administered to pregnant Rhesus macaques during the critical period and effects on structural maturation of the external reproductive organs, menstrual cyclicity, and behavior of offspring monitored.(l3.14) Treatment with these androgens induced masculinization and defeminization of the external genitalia of female offspring. Penile and scrota1 development were evident as was obliteration of the external vaginal orifice. The "androgenized" female offspring showed (9) and (13).
a delay in menarche compared to normal females (36.8 months vs. 29.2). Despite the delay in menarche, these pseudohermaphroditic females subsequently established menstrual cycles that were as stable and regular as those of normal females. This finding constitutes a major departure from studies in rodents, in which prenatal androgen treatment produces an anovulatory sterility syndrome and absence of cyclic release of luteinizing hormone (LH) in female offspring. Despite external virilization of the reproductive organs in Rhesus females, ovulation and normal corpus luteum function occurred on a regular basis.cl5) Male Rhesus offspring showed no abnormalities in the morphology of external genitalia under these conditions.
The pseudohermaphrodite female offspring from mothers injected with testosterone from the 40th to at least the 90th day of gestation displayed patterns of behavior that more closely resembled those of the genetic male than the genetic female. Female pseudohermaphrodites displayed frequencies of mounting similar to those of normal males (Fig. 5) . With their juvenile peers, the "androgenized" females had frequencies of mounting behavior and levels of rough play intermediate between those of normal males and females. A key finding from this study is that a nonaromatizable androgen, DHT, produced the same effect on these behaviors as testosterone. This is in marked contrast to studies in rodents, in which only androgens capable of being aromatized to estrogens, or estrogenic substances themselves, induce masculine gender role behavior after treatment during the critical period.
([))
A complex relationship has been observed between the timing of prenatal treatment of Rhesus monkeys with androgens and the type of masculinized behavior observed in offspring. Mounting of mothers was most pronounced in females androgenized prenatally for at least 50 days beginning on day 40; treatments initiated on gestational day 100 or later had no influence on this kind of juvenile mounting behavior. For rough play and mounting behaviors toward peers, however, treatments begun as late as gestational day 11 5 were as effective as those initiated on day 40. None of the females exposed to androgen from day 100 had genital virilization, demonstrating that masculinization of behavior can be induced independently of genital virilization.cl3) Further insight into the role of testicular androgens on psychosexual behavior in humans has been derived from genetic males with 5u-reductase deficiency.(6) Despite being raised as females in the prepubertal period, 17 of 18 subjects studied underwent a gender identity change at the time of puberty from female to male. This finding underscores the importance of testosterone but not DHT exposure of the CNS in utero, in the prepubertal period, and during puberty as a determinant of male gender identity in humans. Also, gender identity does not appear to be unalterably fixed in early childhood, but most likely becomes more determined with events at puberty. These studies suggest that in addition to environmental factors, prenatal and pubertal exposure to testosterone acts to influence gender identity formation in the normal male. 
